Article Content

Listen on the iPad edition of this issue to hear more interviews from the ASCO Annual meeting in a special edition of the Audio Journal of Oncology for OT. Download the Aug. 25 issue from the OT library of iPad issues and hear:

Figure. No caption a... - Click to enlarge in new windowFigure. No caption available.

* Richard Carvajal on what is being called the first effective treatment for advanced melanoma of the eye.


* Volker Heinemann on his study showing that for patients with metastatic KRAS wild-type expressing colorectal cancer, cetuximab-based treatment added to first-line chemotherapy extended survival compared with use of bevacizumab-based treatment (See article on page 34).


* Suresh Ramalingam on the randomized GALAXY-1 study showing that ganetespib, a heat-shock protein inhibitor, improved the efficacy of chemotherapy in patients with advanced non-small-cell lung cancer.


* Emiel Rutgers on the final analysis of the EORTC AMAROS trial, showing that for breast cancer patients who have a positive sentinel node, radiotherapy is as effective as complete surgical axillary clearance and less toxic (See article on page 33).


* Also offering their expect commentary on each of the four studies, respectively: Lynn Schuchter, Richard Goldberg, Robert Pirker, and Pat Price.



To receive our iPad issues, download the free Oncology Times app from the App Store today! Visit, search in the App Store, or follow the link on